These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 20724128

  • 41. Ent-kauranoids from Isodon rubescens var. taihangensis.
    Han QB, Li RT, Li ML, Mou YK, Tian QE, Li SW, Sun HD.
    J Asian Nat Prod Res; 2005 Feb; 7(1):31-6. PubMed ID: 15621599
    [Abstract] [Full Text] [Related]

  • 42. Evaluation of hydro-alcoholic extract of Eclipta alba for its anticancer potential: an in vitro study.
    Chaudhary H, Dhuna V, Singh J, Kamboj SS, Seshadri S.
    J Ethnopharmacol; 2011 Jun 22; 136(2):363-7. PubMed ID: 21575697
    [Abstract] [Full Text] [Related]

  • 43. Cytotoxic ent-kaurane diterpenoids from Isodon henryi.
    Zhao Y, Huang SX, Yang LB, Pu JX, Xiao WL, Li LM, Lei C, Weng ZY, Han QB, Sun HD.
    Planta Med; 2009 Jan 22; 75(1):65-9. PubMed ID: 19031362
    [Abstract] [Full Text] [Related]

  • 44. Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics.
    Li CY, Wang EQ, Cheng Y, Bao JK.
    Int J Biochem Cell Biol; 2011 May 22; 43(5):701-4. PubMed ID: 21295154
    [Abstract] [Full Text] [Related]

  • 45. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
    Cui Q, Yu JH, Wu JN, Tashiro S, Onodera S, Minami M, Ikejima T.
    Acta Pharmacol Sin; 2007 Jul 22; 28(7):1057-66. PubMed ID: 17588343
    [Abstract] [Full Text] [Related]

  • 46. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
    Dong X, Liu F, Li M.
    Anticancer Drugs; 2016 Apr 22; 27(4):286-99. PubMed ID: 26704389
    [Abstract] [Full Text] [Related]

  • 47. Aqueous extract of Tribulus terrestris Linn induces cell growth arrest and apoptosis by down-regulating NF-κB signaling in liver cancer cells.
    Kim HJ, Kim JC, Min JS, Kim MJ, Kim JA, Kor MH, Yoo HS, Ahn JK.
    J Ethnopharmacol; 2011 Jun 14; 136(1):197-203. PubMed ID: 21549825
    [Abstract] [Full Text] [Related]

  • 48. Proteomic analysis of hepatocellular carcinoma HepG2 cells treated with platycodin D.
    Lu JJ, Lu DZ, Chen YF, Dong YT, Zhang JR, Li T, Tang ZH, Yang Z.
    Chin J Nat Med; 2015 Sep 14; 13(9):673-9. PubMed ID: 26412427
    [Abstract] [Full Text] [Related]

  • 49. Neriifolin from seeds of Cerbera manghas L. induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
    Zhao Q, Guo Y, Feng B, Li L, Huang C, Jiao B.
    Fitoterapia; 2011 Jul 14; 82(5):735-41. PubMed ID: 21459134
    [Abstract] [Full Text] [Related]

  • 50. Structure of kaurane-type diterpenes from Parinari sprucei and their potential anticancer activity.
    Braca A, Armenise A, Morelli I, Mendez J, Mi Q, Chai HB, Swanson SM, Kinghorn AD, De Tommasi N.
    Planta Med; 2004 Jun 14; 70(6):540-50. PubMed ID: 15229806
    [Abstract] [Full Text] [Related]

  • 51. Cytotoxic ent-kaurane diterpenoids from Isodon rubescens var. lushiensis.
    Luo X, Pu JX, Xiao WL, Zhao Y, Gao XM, Li XN, Zhang HB, Wang YY, Li Y, Sun HD.
    J Nat Prod; 2010 Jun 25; 73(6):1112-6. PubMed ID: 20521771
    [Abstract] [Full Text] [Related]

  • 52. Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells.
    Luo D, Yi Y, Peng K, Liu T, Yang J, Liu S, Zhao W, Qu X, Yu W, Gu Y, Wan S.
    Eur J Med Chem; 2019 Sep 15; 178():365-379. PubMed ID: 31200238
    [Abstract] [Full Text] [Related]

  • 53. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
    Yang J, Ren X, Zhang L, Li Y, Cheng B, Xia J.
    Biomed Pharmacother; 2018 Apr 15; 100():226-232. PubMed ID: 29432993
    [Abstract] [Full Text] [Related]

  • 54. Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo.
    Song M, Liu X, Liu K, Zhao R, Huang H, Shi Y, Zhang M, Zhou S, Xie H, Chen H, Li Y, Zheng Y, Wu Q, Liu F, Li E, Bode AM, Dong Z, Lee MH.
    Mol Cancer Ther; 2018 Jul 15; 17(7):1540-1553. PubMed ID: 29695636
    [Abstract] [Full Text] [Related]

  • 55. Cytotoxic ent-kauranoids from Isodon parvifolius.
    Li LM, Li GY, Li SH, Weng ZY, Xiao WL, Han QB, Ding LS, Lou LG, Sun HD.
    Chem Biodivers; 2006 Sep 15; 3(9):1031-8. PubMed ID: 17193336
    [Abstract] [Full Text] [Related]

  • 56. Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo.
    Zhou GB, Chen SJ, Wang ZY, Chen Z.
    Cell Res; 2007 Apr 15; 17(4):274-6. PubMed ID: 17426700
    [No Abstract] [Full Text] [Related]

  • 57. ent-Kaurane Diterpenoids from Isodon nervosus.
    Li LM, Li GY, Ding LS, Yang LB, Zhao Y, Pu JX, Xiao WL, Han QB, Sun HD.
    J Nat Prod; 2008 Apr 15; 71(4):684-8. PubMed ID: 18345641
    [Abstract] [Full Text] [Related]

  • 58. Chemopreventive action of Lygodium flexuosum extract in human hepatoma PLC/PRF/5 and Hep 3B cells.
    Wills PJ, Asha VV.
    J Ethnopharmacol; 2009 Mar 18; 122(2):294-303. PubMed ID: 19168119
    [Abstract] [Full Text] [Related]

  • 59. Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells.
    Kang N, Cao SJ, Zhou Y, He H, Tashiro S, Onodera S, Qiu F, Ikejima T.
    Int J Oncol; 2015 Dec 18; 47(6):2045-56. PubMed ID: 26648189
    [Abstract] [Full Text] [Related]

  • 60. Proteomic and functional analyses demonstrate the involvement of oxidative stress in the anticancer activities of oridonin in HepG2 cells.
    Wang H, Ye Y, Yu ZL.
    Oncol Rep; 2014 May 18; 31(5):2165-72. PubMed ID: 24627081
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.